SWM
TLSA icon

Spire Wealth Management’s Tiziana Life Sciences TLSA Stock Holding History

Spire Wealth Management’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-750
Closed -$1K – 3003
2021
Q3 		$1K Hold
750
– – ﹤0.01% 2546
2021
Q2 		$2K Sell
750
-10,000
-93% -$24.7K ﹤0.01% 2503
2021
Q1 		$29K Buy
+10,750
New +$35.7K ﹤0.01% 1984

Other funds holding TLSA

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFP
Ausdal Financial Partners Davenport, Iowa $2.25B AUM 20.11% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Spire Wealth Management's TLSA Position: Q4 2021 in Review

Spire Wealth Management sold out of Tiziana Life Sciences (TLSA) in Q4 2021, closing a stake of 750 shares — an estimated $1K sold.

Spire Wealth Management first reported a position in TLSA in Q1 2021 and held it in 3 quarters. The position peaked at $29K in Q1 2021. 23 funds tracked by Wall St. Rank hold TLSA as of Q4 2021.

  • Spire Wealth Management reported no remaining Tiziana Life Sciences position as of Q4 2021 after selling out during the quarter.
  • Spire Wealth Management sold 750 Tiziana Life Sciences shares in Q4 2021, an estimated $1K.
  • Spire Wealth Management first reported a position in Tiziana Life Sciences in Q1 2021 and held it in 3 quarters.
  • Spire Wealth Management's Tiziana Life Sciences position peaked at $29K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q4 2021.

Based on Spire Wealth Management's 13F filing for Q4 2021, filed 14 Jan 2022.